Plain-English translation of NCT07181590 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying the Volt PFA System, a balloon-based catheter procedure designed to treat atrial fibrillation — a condition where the heart beats irregularly. The study will track how safely and effectively this treatment works in patients like you who either haven't benefited from medications or can't take them.
Atrial fibrillation can cause serious symptoms and complications, and many patients don't respond well enough to heart medications. This trial exists to gather real-world evidence about whether this newer balloon-based treatment approach is a safe and effective option for people in your situation.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, you will undergo a catheter ablation procedure using the Volt PFA System — a minimally invasive treatment where a thin tube with a special balloon is threaded to your heart to correct the irregular rhythm. You will attend pre-procedure visits for testing and evaluation, have the procedure itself performed by a heart specialist, and then return for follow-up visits and tests to monitor your recovery and whether the treatment is working. The study will track your outcomes over a defined follow-up period to gather safety and effectiveness data.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Austria
Belgium
Denmark
France